Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

BACKGROUND: Real-world data on usage and associated outcomes with hereditary angioedema (HAE)-specific medications introduced to the United States (US) market since 2009 are very limited. The purpose of this retrospective study was to evaluate real-world treatment patterns of HAE-specific medication...

Descripción completa

Detalles Bibliográficos
Autores principales: Riedl, Marc A, Banerji, Aleena, Manning, Michael E, Burrell, Earl, Joshi, Namita, Patel, Dipen, Machnig, Thomas, Tai, Ming-Hui, Watson, Douglas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186115/
https://www.ncbi.nlm.nih.gov/pubmed/30314518
http://dx.doi.org/10.1186/s13023-018-0922-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186115/
https://www.ncbi.nlm.nih.gov/pubmed/30314518
http://dx.doi.org/10.1186/s13023-018-0922-3

Ejemplares similares